Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of MMP-13 (unknown origin) using QXL520-gamma-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2 as fluorogenic substrate at 100 uM preincubated for 10 mins followed by substrate addition and measured for 25 mins by microplate reader assay
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of MMP-13 (unknown origin) using QXL520-gamma-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2 as fluorogenic substrate at 1 to 100 uM preincubated for 10 mins followed by substrate addition and measured for 25 mins by microplate reader assay
Inhibition of MMP-13 (unknown origin) using QXL520-gamma-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2 as fluorogenic substrate preincubated for 10 mins followed by substrate addition and measured for 25 mins by microplate reader assay
Inhibition of human MMP-13
Assay data:5 Active, 5 Tested
Inhibition of MMP-13 (unknown origin)
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
Inhibition of recombinant human MMP13
Inhibition of MMP13 (unknown origin) at 50 uM relative to control
Assay data:2 Tested
Inhibition of MMP13 (unknown origin) by FRET assay
Inhibition of MMP-13 (unknown origin) at 20 uM by fluorometric assay
Inhibition of human MMP13 using Dnp-Pro-Cha-Gly-Cys(ME)-His-Ala-Lys(Nma)-NH2 as substrate preincubated for 0.5 hrs followed by substrate addition and measured after 6 hrs by fluorimeter analysis
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of rat MMP-13
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of recombinant human MMP13 using Dnp-Pro-Cha-Gly-Cys(ME)-His-Ala-Lys(Nma)-NH2 as substrate by fluorometer analysis
Inhibition of recombinant human MMP13 using Mca-Pro-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 20 to 30 mins by fluorescence microplate reader analysis
Inhibition of human MMP13 using Dnp-Pro-Cha-Gly-Cys(Me)-His-Ala-Lys(Nma)-NH2 substrate by fluorimetric analysis
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Inhibition of MMP-13 (unknown origin) assessed as inhibition constant
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Assay data:3 Active, 2 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
Inhibition Assay from US Patent US11608309: "Curcumin analogues as zinc chelators and their uses"
Assay data:4 Active, 2 Activity ≤ 1 µM, 8 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Inhibition of recombinant human MMP13 using APMA and fTHP-15(FAM) as substrate preincubated for 30 mins followed by substrate addition by fluorescence microplate reader assay
Assay data:26 Active, 24 Activity ≤ 1 µM, 28 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Selectivity interaction (MMPs panel (FRET assay, + 1.25 % HSA)) EUB0000730a MMP13
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on